Compare Invesco DB Oil Fund (DBO) vs Medtronic PLC (MDT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Invesco DB Oil Fund vs Medtronic PLC — how do they compare? Invesco DB Oil Fund trades at $21.06, while Medtronic PLC trades at $90.48 (market cap $114.45B). The key difference: Medtronic PLC pays a 3.22% dividend while Invesco DB Oil Fund pays none, and Invesco DB Oil Fund is trading nearer its 52-week high, Medtronic PLC nearer its low. Which is the better fit depends on your goals.
| DBO | MDT | |
|---|---|---|
Sector | Commodities - Energy | Health |
52-Week High | $23.80 | $105.35 |
52-Week Low | $11.98 | $73.75 |
Market Cap | — | $114.45B |
Enterprise Value | — | $133.19B |
Dividend Yield | — | 3.22% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DBO trades at $19.59, down 0.41% on the day, with a bearish technical signal from moving averages and oscillators showing neutrality. The stock faces resistance at $20 and support at $19. Recent news highlights oil price volatility due to Middle East tensions, particularly the Strait of Hormuz deadlock, which may impact energy sector stocks like DBO.
The outlook for DBO is cautious amid geopolitical risks and technical bearishness. Investment opportunities hinge on resolution of oil supply constraints, while risks include prolonged Middle East instability and potential earnings pressure from fluctuating crude prices. Wall Street sentiment appears mixed, with no clear consensus on near-term direction.
Medtronic (MDT) trades at $87.16, up 1.44% today, with a bullish technical signal and consistent earnings beats. The company reported Q1 2026 EPS of $1.55, exceeding expectations, and maintains solid fundamentals with a 13.2% net income margin and $33.54B in revenue for 2025. Recent news highlights growth in cardiac ablation and the Hugo robotic platform, with management guiding for 11.75% organic revenue growth in Q1 2027.
The outlook is positive, supported by analyst consensus of a $98.75 price target and 60% buy ratings. Key opportunities include dividend stability and innovation in medical technology, while risks involve rising debt levels and competitive pressures. The stock's current valuation at a P/E of 23.37 offers moderate upside if execution continues.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Invesco DB Oil Fund
DBO provides exposure to WTI crude oil prices through futures contracts. It is designed for investors seeking a way to invest in the performance of the fossil fuel market without purchasing physical oil barrels.
Read more on DBO →About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →
